Important Safety Information: SRT-2104
What is SRT-2104?
SRT-2104 is an experimental small molecule that functions as a selective activator of sirtuin 1 (SIRT1), a protein involved in cellular metabolism, aging, and stress resistance. It is currently being investigated in research settings for its potential applications in metabolic disorders, cardiovascular diseases, and age-related conditions. SRT-2104 is not approved for medical use.
Warnings and Precautions
- Research Use Only
SRT-2104 is an investigational compound and has not been approved by regulatory authorities (e.g., FDA, EMA) for therapeutic use. Any use outside of research settings is experimental and may carry significant risks. - Contraindications
- Do not use if you are allergic to SRT-2104 or any of its components.
- Avoid use if you are pregnant, breastfeeding, or planning to conceive, as the effects of SRT-2104 on fetal or maternal health have not been established.
- Patients with active cancer or a history of cancer should consult a healthcare provider before use, as SIRT1 activation may theoretically affect cellular proliferation.
- Potential Side Effects
Although clinical data on SRT-2104 is limited, potential side effects reported in studies include:- Mild gastrointestinal discomfort, such as nausea or diarrhea.
- Headache or dizziness.
- Changes in blood pressure or heart rate.
- Fatigue or sleep disturbances.
- Allergic reactions, including rash or itching.
- Precautions for Specific Conditions
- Cardiovascular Conditions: SRT-2104 may influence cardiovascular health. Patients with a history of heart disease, hypertension, or arrhythmias should use this compound cautiously under medical supervision.
- Metabolic Disorders: Individuals with diabetes or metabolic syndrome should monitor blood glucose levels, as SRT-2104 may affect glucose metabolism.
Drug Interactions
- SRT-2104 may interact with medications affecting metabolic pathways, such as insulin, glucose-lowering agents, or lipid-lowering therapies.
- Inform your healthcare provider of all medications, supplements, and therapies to avoid potential interactions.
Usage Instructions
- Administration
- SRT-2104 is typically administered orally in research or investigational settings. Follow instructions provided by your research supervisor or healthcare provider.
- Dosage
- Dosages vary depending on the research protocol. Adhere strictly to the prescribed regimen, and do not exceed the recommended dose.
- Monitoring
- Regular monitoring of biomarkers such as glucose levels, lipid profiles, and cardiovascular markers is essential during SRT-2104 use to ensure safety and effectiveness.
Storage and Handling
- Store SRT-2104 in a cool, dry place, away from direct sunlight and moisture.
- Follow any specific storage guidelines provided by the manufacturer or research protocol.
- Keep out of reach of children and unauthorized personnel.
Disclaimers
- SRT-2104 is not approved by regulatory authorities for human consumption or therapeutic use.
- The long-term safety and efficacy of SRT-2104 have not been established.
- Off-label or unauthorized use may result in serious health risks and complications.
If you experience adverse effects or have concerns about SRT-2104, discontinue use and consult a licensed healthcare provider immediately. For further information, contact the product distributor or manufacturer.